Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Taiwan site entry changed from Taoyuan, Taiwan, 33305 to Taoyuan City, Taiwan, 33305. This clarifies the exact city designation for that study site.
    Difference
    0.0%
    Check dated 2026-05-08T12:18:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov page revision/version number from “v3.5.2” to “v3.5.3,” reflecting a site update rather than a change to the study’s details.
    Difference
    0.0%
    Check dated 2026-04-24T06:28:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:26.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:09:28.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Results posted on 2026-03-06 introduce a comprehensive Results section with primary and secondary efficacy outcomes (OCS exposure, BPDAI scores, pruritus NRS, ABQOL, BP involvement, and autoantibody titers) plus safety data through Week 64. Several previously reported metrics (e.g., sustained remission proportions and some BPDAI-related endpoints) were removed.
    Difference
    6%
    Check dated 2026-03-12T00:40:58.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    A new site revision entry (Revision: v3.4.2) was added, and the notice about a lapse in government funding was removed; these are minor administrative updates that do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:28:50.000Z thumbnail image

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.